Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06786494 · ClinicalTrials.gov registry record · NA
Tart Cherry Juice for Sleep in Older Adults With Insomnia: A Pilot Study of Feasibility and Comprehensive Mechanisms
A NA study of Insomnia and Sleep Problems, sponsored by Courtney Millar.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06786494: Completed NA study of Insomnia and Sleep Problems, sponsored by Courtney Millar.
NCT06786494 is a NA study of Insomnia and Sleep Problems that has completed, run by Courtney Millar. The registered enrollment target is 20 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06786494, a NA study of Insomnia and Sleep Problems, has completed, sponsored by Courtney Millar.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is test if a study that asks older adults with sleep problems to consume tart cherry products is feasible and determine if it can change sleep patterns. This study is a total of 12 weeks. Participants will be asked to consume tart cherry juice for 4 weeks and the placebo juice for 4 weeks, while wearing a digital monitor that measures sleep. Blood (about 3 teaspoons) and urine (about 2 tablespoons) samples will be taken before and after consuming both juices to measure certain biological markers related to sleep.
Primary Outcome
Number of individuals that need to be screened to be enrolled that are randomized to the intervention.
Conditions Studied
Interventions
- OTHER Placebo juice
- OTHER Tart Cherry Juice
Study Locations (1)
Massachusetts
- Hebrew Rehabilitation Center - Roslindale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-01-15 |
| Est. Completion | 2025-08-13 |
| Phase | NA |
What the finished NCT06786494 record still lists
NCT06786494 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Placebo juice is the first listed.
NCT06786494 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06786494 about?
NCT06786494 is a clinical study titled "Tart Cherry Juice for Sleep in Older Adults With Insomnia: A Pilot Study of Feasibility and Comprehensive Mechanisms". The purpose of this research study is test if a study that asks older adults with sleep problems to consume tart cherry products is feasible and determine if it can change sleep patterns. This study is a total of 12 weeks. Participants will be asked to consume tart cherry juice for 4 weeks and the p...
What is the current status of trial NCT06786494?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2025-01-15. Estimated completion is 2025-08-13.
What conditions does trial NCT06786494 study?
This clinical trial studies the following conditions: Insomnia, Sleep Problems.
What interventions are being tested in trial NCT06786494?
The interventions under investigation include: Placebo juice (OTHER), Tart Cherry Juice (OTHER).
Who is sponsoring clinical trial NCT06786494?
This trial is sponsored by Courtney Millar, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06786494 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06786494's enrollment target sits among peer trials
20 137th of 151 higher than 12 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI